Treatment of neurological disorders

Details Treatment of neurological disorders Treatment of neurological disorders

1994-03-08

1995-07-04

Cintins, Marianne M.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514313, A61K 3144

Patent

active

054300398

ABSTRACT:
A method for inhibiting neuronal cell death in a mammal resulting from a disorder of the central or peripheral nervous system including administering to the mammal a neuronal cell death inhibitng amount of a preparation including any of mepacrine, chloroquine, or hydroxychloroquine, the preparation being essentially free of colchicine.

REFERENCES:
patent: 3830918 (1974-08-01), Molnar et al.
patent: 4840972 (1989-06-01), Effland et al.
Rosner et al., Therapie, XXII:345-354, 1967, "Influence de La chloroquine et de L'hydroxychloroquine sur L'evolution des troubles moteurs post-ischemiques," with attached translation.
Rosner et al., "Therapie, XXII:355-360, 1967, Hydroxychloroquine et resistance corticale e L'anoxie asphyxique," with attached translation.
Larsen et al., Therapie, 33:651-660, 1978, "Modele d'ischemie cerebrale experimentale par microspheres chez le Rat Etude de l'effet de deux extraits de Ginkgo biloba et du naftidrofuryl," with attached translation.
Faden et al., Science, 244:798-800 (1989).
Choi et al., Annual Rev. Of Neuros., 13:171-182 (1990).
Hostetler and Jellison, Mol. Cell. Biochem., 88:77-82 (1989).
Lazarewicz et al., Neuropharmacol., 27:765-769 (1988).
Otamiri and Tagesson, Am. J. Surg., 157:562-565 (1989).
Otani et al., Am. J. Physiol., 257:H252-H258 (1989).
Giulian and Robertson, Ann. Neurol., 27:33-42 (1990).
Murphy et al., FASEB J, 4:1624-1633 (1990).
Badalamente et al., J. of Hand Surgery, 11:337-340 (1986).
Iizuka et al., J. of Neurosurgery, 65:92-98 (1986).
Giulian et al., J. of Neurosci, 9:4416-4429 (1989).
Siman et al., J. of Neurosci., 9:1579-1590 (1989).
Matsuzawa et al., J. Biol. Chem., 255:5190-5194 (1980).
Siesjo (1981), J. Cereb. Blood Flow Metabol., 1:155-185 (1981).
Yawo and Kuno, Science, 222:1351-1353 (1983).
Au et al., J. Cell Biochem, 27:449-453 (1985).
Barbour et al., Nature, 342:918-920 (1989).
DeGeorge et al., J. Neurosci. Res., 21:323-332 (1988).
Reuter, Nature, 301:569-574 (1983).
Goldschmidt et al., Proc. Natl. Acad. Sci. 77:3047-3051, (1980).
Chien et al., The J. of Biol. Chem. 253:4809-4817, (1978).
Norris et al. 1986, British Medical J, vol. 292 pp. 21-23.
Jastremski et al. 1989, JAMA, vol. 262(24) pp. 3427-3430.
Jun et al. CA 68:113285u 1968.
Rosner et al. CA 66:114464x 1967.
Larsen et al. CA 90:115360t 1979.

Affiliated with

Also associated with

Rating

Treatment of neurological disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of neurological disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of neurological disorders will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-760315